Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A narrative review

Nutr Clin Pract. 2024 Apr 26. doi: 10.1002/ncp.11152. Online ahead of print.ABSTRACTPatients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies. In consequence, these critically ill patients frequently present with malnutrition and pathophysiological alterations that create challenges for the delivery of medical nutrition therapy (MNT) in the ICU. Frequent screening, gauging tolerance, and monitoring nutrition status are mandatory to provide individualized MNT and achieve nutrition objectives. The present review discusses how HM impact GI function and nutrition status, the importance of MNT in patients with HM, and specific considerations for guidance in providing adequate MNT to these patients when admitted to the ICU.PMID:38666811 | DOI:10.1002/ncp.11152
Source: Nutrition in Clinical Practice - Category: Nutrition Authors: Source Type: research